Stay informed with the latest litigation news. Explore now

Amicus Therapeutics Us, Llc V. Teva Pharmaceuticals Usa, Inc. - 1:24-cv-00696

Explore the details of the Amicus Therapeutics Us, Llc V. Teva Pharmaceuticals Usa, Inc. case under case number 1:24-cv-00696 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00696
Filing Date
Jun 13, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Amicus Therapeutics US, LLC -
Teva Pharmaceuticals, Inc. -

Patents Involved

There is a single patent involved in this case.

Application NumberPatent Number
-US11833164B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 11, 2024ANSWER to 1 Complaint,, COUNTERCLAIM against All Plaintiffs by Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc..(DiBenedetto, Emily) (Entered: 07/11/2024)PACER Document
Jul 12, 2024ORDER: IT IS ORDERED that, on or before August 12, 2024, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 8/12/2024.) Signed by Judge Colm F. Connolly on 7/12/2024. Associated Cases: 1:24-cv-00696-CFC, 1:24-cv-00698-CFC(nmf) (Entered: 07/12/2024)PACER Document
Jul 16, 2024Joint MOTION to Consolidate Cases 24-cv-696-CFC into Lead Case No. 22-cv-1461-CJB - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Text of Proposed Order)(Stover, Chad) (Entered: 07/16/2024)PACER Document
Jul 29, 2024CONSENT to Jurisdiction by U.S. Magistrate Judge filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. Case reassigned to Magistrate Judge Christopher J. Burke. Signed by Judge Colm F. Connolly on 7/29/2024. (nmf) (Entered: 07/29/2024)PACER Document
Jun 18, 2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-00696-CFC, 1:24-cv-00698-CFC (rjb)PACER Document
Jun 27, 2024SO ORDERED, re 10 STIPULATION TO EXTEND TIME for Defendants to Answer Complaint to July 11, 2024, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 7/11/2024; Teva Pharmaceuticals, Inc. answer due 7/11/2024. Ordered by Judge Colm F. Connolly on 6/27/2024. (kmd)PACER Document
Jul 29, 2024Remark: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf Associated Cases: 1:24-cv-00696-CJB, 1:24-cv-00698-CJB(smg)PACER Document
Jul 29, 2024Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf Associated Cases: 1:24-cv-00696-CJB, 1:24-cv-00698-CJB(smg)PACER Document
Jul 31, 2024ORAL ORDER: The Court, having reviewed the parties’ Joint Motion to Consolidate Cases ("Motion"), (D.I. 14 ), hereby ORDERS that the Motion is GRANTED. All papers shall be filed be filed in lead action Civil Action No. 22-1461-CJB. The Protective Order (Civil Action No. 22-1461-CJB (consolidated), D.I. 77), ESI Order (Civil Action No. 22-1461-CJB (consolidated), D.I. 42), and Scheduling Order (Civil Action No. 22-1461-CJB (consolidated), D.I. 29, as amended by D.I. 137) shall govern the consolidated action. Ordered by Judge Christopher J. Burke on 7/31/2024. (smg) (Entered: 07/31/2024)PACER Document
Oct 24, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,833,164. (Attachments: # 1 Consent Judgment)(smg) (Entered: 10/24/2024)PACER Document
Oct 24, 2024CASE CLOSED per Consent Judgment entered in lead case 22-cv-1461-CJB, D.I. 185. Associated Cases: 1:22-cv-01462-CJB, 1:24-cv-00696-CJB(smg)PACER Document
Jul 16, 2024Joint MOTION to Consolidate Cases 24-cv-696-CFC into Lead Case No. 22-cv-1461-CJB - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Text of Proposed Order)(Stover, Chad) (Entered: 07/16/2024)Attachment
Jun 13, 2024Summons Issued as to Teva Pharmaceutical Industries Ltd. on 6/13/2024; Teva Pharmaceuticals USA, Inc. on 6/13/2024; Teva Pharmaceuticals, Inc. on 6/13/2024. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 06/14/2024)Attachment
Jun 13, 2024Summons Issued as to Teva Pharmaceutical Industries Ltd. on 6/13/2024; Teva Pharmaceuticals USA, Inc. on 6/13/2024; Teva Pharmaceuticals, Inc. on 6/13/2024. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 06/14/2024)Attachment
Jun 13, 2024COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4429542.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 06/14/2024)Attachment
Jun 13, 2024COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4429542.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 06/14/2024)Attachment